Price
CHART BY
Frequently asked questions
What is Guardant Health's market capitalization?
The market capitalization of Guardant Health is $21.67B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Guardant Health?
Guardant Health's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$3.50. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Guardant Health's stock?
Currently, 28 analysts cover Guardant Health's stock, with a consensus target price of $198.17. Analyst ratings provide insights into the stock's expected performance.
What is Guardant Health's revenue over the trailing twelve months?
Over the trailing twelve months, Guardant Health reported a revenue of $1.18B.
What is the EBITDA for Guardant Health?
Guardant Health's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$431.28M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Guardant Health?
Guardant Health has a free cash flow of -$228.54M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Guardant Health have, and what sector and industry does it belong to?
Guardant Health employs approximately 2,506 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Guardant Health's shares?
The free float of Guardant Health is 128.77M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $21.67B
- EPS (TTM)
- -$3.50
- Free Float
- 128.77M
- Revenue (TTM)
- $1.18B
- EBITDA (TTM)
- -$431.28M
- Free Cashflow (TTM)
- -$228.54M
Pricing
- 1D span
- $160.34$169.59
- 52W span
- $53.44$176.26
Analyst Ratings
The price target is $198.17 and the stock is covered by 28 analysts.
Buy
24
Hold
3
Sell
1
Information
Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.
- Employees
- 2,506
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- GH
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet